Serstech AB

Stockholm Stock Exchange SERT.ST

Serstech AB Operating Income for the year ending December 31, 2023: USD -123.28 K

Serstech AB Operating Income is USD -123.28 K for the year ending December 31, 2023, a 95.59% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Serstech AB Operating Income for the year ending December 31, 2022 was USD -2.80 M, a -137.87% change year over year.
  • Serstech AB Operating Income for the year ending December 31, 2021 was USD -1.18 M, a -48.38% change year over year.
  • Serstech AB Operating Income for the year ending December 31, 2020 was USD -792.16 K, a 51.92% change year over year.
  • Serstech AB Operating Income for the year ending December 31, 2019 was USD -1.65 M, a -21.67% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
Stockholm Stock Exchange: SERT.ST

Serstech AB

CEO Mr. Stefan Sandor
IPO Date Aug. 28, 2013
Location Sweden
Headquarters Aldermansgatan 13
Employees 25
Sector Materials
Industries
Description

Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.

Similar companies

ENZY.ST

Enzymatica AB (publ)

USD 0.15

-2.28%

POLYG.ST

Polygiene Group AB

USD 1.20

-0.80%

ERMA.ST

Enorama Pharma AB (publ)

USD 0.29

3.82%

SPRINT.ST

Sprint Bioscience AB (publ)

USD 0.14

1.34%

StockViz Staff

January 15, 2025

Any question? Send us an email